deltatrials
Unknown OBSERVATIONAL NCT04156360

Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Updated 5 times since 2019 Last updated: Nov 5, 2019 Started: Nov 1, 2019 Primary completion: Nov 1, 2020 Completion: Jun 1, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Healthy and Pulmonary Nodule, this trial is ongoing. The trial is conducted by Shanghai Pulmonary Hospital, Shanghai, China and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotNot Yet Recruiting~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  3. Jan 2022 — Jul 2024 [monthly]

    Unknown Status

    Status: Not Yet RecruitingUnknown Status

  4. Jan 2021 — Jan 2022 [monthly]

    Not Yet Recruiting

  5. Dec 2019 — Jan 2021 [monthly]

    Not Yet Recruiting

    First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Shanghai Pulmonary Hospital, Shanghai, China
Data source: Shanghai Pulmonary Hospital, Shanghai, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.